U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07217327) titled 'The DistaSense VITALS Study' on July 30.
Brief Summary: A prospective, non-significant risk study designed to validate the performance of the DistaSense Contactless Sensor and algorithm for detecting heart rate and respiratory rate, compared to gold standard reference technology.
Study Start Date: Aug. 13
Study Type: OBSERVATIONAL
Condition:
Detection of Heart Rate and Respiratory Rate
Intervention:
DIAGNOSTIC_TEST: DistaSense and Polysomnography
All subjects will be evaluated by DistaSense and reference device for respiratory rate and heart rate.
Recruitment Status: RECRUITING
Sponsor: Life Detection Technologies
Disclaim...